Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy"

Affiliations

• ¹ Allergy Therapeutics PLC, Worthing, UK.
• ² Children and Adolescents Deptartment, Allergology, Pulmonology & Cystic fibrosis, Goethe University, Frankfurt, Germany.
• ³ Bernstein Clinical Research Center LLC, Cincinnati, Ohio, USA.
• ⁴ Department of Botany, University of Innsbruck, Innsbruck, Austria.
• ⁵ Department of Otorhinolaryngology, Wiener Gesundheitsverbund, Hospital Hietzing, Vienna, Austria.
• ⁶ Clinic and Polyclinic of Otorhinolaryngology, University Clinic Carl Gustav Carus, Dresden, Germany.
• ⁷ Allergy Partners of Western North Carolina, Asheville, North Carolina, USA.
• ⁸ ENT Research-Institut für klinische Studien, Essen, Germany.
• ⁹ Bluegrass Allergy Research, Lexington, Kentucky, USA.
• ¹⁰ Hamburger Institut für Therapieforschung GmbH, Hamburg, Germany.
• ¹¹ Studienzentrum Dr. Sabine Laßmann, Saalfeld, Germany.
• ¹² Department of Dermatology and Allergy-Charite Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany.
• ¹³ Chesapeake Clinical Research, Inc., White Marsh, Maryland, USA.
• ¹⁴ Allergy Partners of New Jersey, Ocean, New Jersey, USA.
• ¹⁵ Certified Research Associates, Cortland, New York, USA.
• ¹⁶ Allergy Asthma & Sinus Center S.C., Greenfield, Wisconsin, USA.
• ¹⁷ IMSB (Institute of Computational Biology and Medical Statistics), University at Cologne, Cologne, Germany.
• ¹⁸ ClinCompetence, Cologne, Germany.
• ¹⁹ Department of National Heart and Lung Institute, Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Imperial College London, London, UK.
• ²⁰ Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, UK.
• ²¹ Division of Allergy and Immunology, Department of Internal Medicine, George Washington University Hospital, Washington, District of Columbia, USA.